Sign In
Buy AXGN
$40.63
+1.17 (+2.97%)
At Close: Jun 03, 2026
Analysts Anticipate AxoGen, Inc (NASDAQ:AXGN) Will Announce Earnings of -$0.08 Per Share
09:50am, Tuesday, 28'th Jan 2020
Wall Street brokerages expect AxoGen, Inc (NASDAQ:AXGN) to post ($0.08) earnings per share for the current fiscal quarter, according to Zacks. Zero analysts have issued estimates for AxoGen’s earnin
BidaskClub Lowers AxoGen (NASDAQ:AXGN) to Strong Sell
11:42am, Tuesday, 14'th Jan 2020
BidaskClub lowered shares of AxoGen (NASDAQ:AXGN) from a sell rating to a strong sell rating in a report released on Friday morning, BidAskClub reports. Several other brokerages also recently issued r
AxoGen reports preliminary Q4 and FY 2019 revenue outlook
02:21pm, Monday, 13'th Jan 2020
AxoGen (NASDAQ:AXGN) announces preliminary Q4 and FY 2019 revenue guidance.Q4 and FY revenue is expected to be at least $28.1M and $106.6M, respectively.Ended Q4 with 109 direct sales representatives
AxoGen sees FY20 revenue $124M-$128M, consensus $132.38M AXGN
12:17pm, Monday, 13'th Jan 2020
AxoGen sees FY20 revenue $124M-$128M, consensus $132.38M AXGN
AxoGen sees FY19 revenue at least $106.6M, consensus $107.76M AXGN
12:16pm, Monday, 13'th Jan 2020
AxoGen sees FY19 revenue at least $106.6M, consensus $107.76M AXGN
AxoGen sees Q4 revenue at least $28.1M, consensus $29.22M AXGN
12:16pm, Monday, 13'th Jan 2020
AxoGen sees Q4 revenue at least $28.1M, consensus $29.22M AXGN
Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2019 and Provides 2020 Annual Guidance
12:00pm, Monday, 13'th Jan 2020
Axogen, Inc. (AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced preliminary unaudited fourth quarter and full-year 2019 re
Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2019 and Provides 2020 Annual Guidance
12:00pm, Monday, 13'th Jan 2020
ALACHUA, Fla., Jan. 13, 2020 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions...
We’re Hopeful That AxoGen (NASDAQ:AXGN) Will Use Its Cash Wisely
11:23am, Friday, 10'th Jan 2020
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...
Stock Analysts' Downgrades for January, 10th (AAVVF, AAWW, ADMA, AIQUY, AMNB, AMRN, AOBC, AOIFF, ATOM, ATRI)
07:22am, Friday, 10'th Jan 2020
Stock Analysts’ downgrades for Friday, January 10th: Advantage Oil & Gas (OTCMKTS:AAVVF) was downgraded by analysts at ValuEngine from a hold rating to a sell rating. Atlas Air Worldwide (NASDAQ:AAW
Axogen Sponsored RANGER® Registry Reaches 2,000 Nerve Repair Enrollment Milestone
12:00pm, Wednesday, 08'th Jan 2020
Axogen, Inc. (AXGN), a global leader in developing and marketing innovative surgical solutions for damage or transection to peripheral nerves, today announced that its RANGER registry enrollment has r
